Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc (DAWN) is known on NASDAQ - United States, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerDAWN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodFY2025
- RevenueUSD 158.18M
- Revenue growth20.6%
- Net income-USD 107.32M
- Free cash flow-USD 107.58M
- Gross margin89.1%